-transparent.png){kind=logo}
The aim of the present study was to develop and validate a rapid assay for genotyping of CYP1B1 codon 432-polymorphism. The described method is a single tube assay and combines both rapid-cycle polymerase chain reaction (PCR) with real-time monitoring by amplification and generation of the melting profiles of an allele-specific fluorescent probe. With this method 300 samples were analysed from healthy, unrelated Germans. Genotype frequency determined for the mutated allele CYP1B1*2 was 0.40. The results show that genotyping of CYP1B1 codon 432-polymorphism with a real-time fluorescence PCR method is a rapid and reliable assay for the analysis of large numbers of samples.
Related Publications
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
November 2006,
Fertility and sterility,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
July 2007,
Basic & clinical pharmacology & toxicology,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
February 2000,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
July 2017,
European journal of medicinal chemistry,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
January 2002,
Methods in enzymology,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
January 2015,
Journal of ophthalmic & vision research,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
October 2003,
Clinical chemistry,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
November 1998,
Cancer research,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
December 1998,
Clinical chemistry,
T Brüning, and
J Abel, and
B Koch, and
K Lorenzen, and
V Harth, and
S Donat, and
A Sachinidis, and
H Vetter, and
H M Bolt, and
Y Ko
September 2006,
Cancer research,
